Crestline Management’s Dianthus Therapeutics DNTH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,633	Closed	-$31K	–	227
2022 Q2	$31K	Sell	1,633 -21	-1%	-$399	﹤0.01%	219
2022 Q1	$77K	Buy	+1,654	New	+$77K	0.01%	252